Загрузка...
Production of truncated MBD4 protein by frameshift mutation in DNA mismatch repair-deficient cells enhances 5-fluorouracil sensitivity that is independent of hMLH1 status
Methyl-CpG binding domain protein 4 (MBD4) is a DNA glycosylase that can remove 5-fluorodeoxyuracil from DNA as well as repair T:G or U:G mismatches. MBD4 is a target for frameshift mutation with DNA mismatch repair (MMR) deficiency, creating a truncated MBD4 protein (TruMBD4) that lacks its glycosy...
Сохранить в:
| Опубликовано в: : | Cancer Biol Ther |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4970528/ https://ncbi.nlm.nih.gov/pubmed/27115207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2016.1178430 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|